Xylooligosaccharides (XOS) and arabinoxylooligosaccharides (AXOS), potential prebiotics, can be produced from rice bran arabinoxylan (RBAX) using commercial endoxylanase enzymes. However, differences in rice bran cultivars and endoxylanase enzyme types may affect extracted oligosaccharides (OS) yields. This study investigated extracted OS structures derived from three different RBAX using two commercial endoxylanase enzymes. RBAX extracted from commercially defatted rice bran (CDRB) yielded the

more »

... greatest OS amount (456.69 mg/g RBAX), followed by that of the San-Pah-Tawng1 (SPT1) cultivar (231.7 mg/g RBAX), and lastly, the Chai-Nat1 (CN1) cultivar (172.57 mg/g RBAX), as evidenced via Ultraflo L enzyme hydrolysis. Ultraflo Max enzyme hydrolysis produced a similar trend, however, OS amounts from all RBAX sources were remarkably lower (83.39 mg/g RBAX extracted from CDRB, 27.05 mg/g RBAX from SPT1 cultivar, and 21.53 mg/g RBAX from CN1 cultivar). Interestingly, 32-α-L-Araf-(1-4)-β-D-xylobiose (A3X) was the primary AXOS product in all RBAX hydrolysates prepared by Ultraflo Max. RBAX extracted from CDRB solubilized by Ultraflo L (45.67% weight of RBAX) had higher OS yields than that obtained via Ultraflo Max (8.3% weight of RBAX). Ultraflo L was therefore a suitable commercial enzyme for short-chain OS conversion from RBAX.